---
figid: PMC4172307__nihms-553334-f0001
figlink: /pmc/articles/PMC4172307/figure/F1/
number: Figure 1
caption: 'Tumstatin, endostatin, arresten and canstatin interact with αVβ3/ α3β1,
  α5β1, α1β1 and αVβ3/ αVβ5 integrins respectively, to inhibit the phosphorylation
  of focal adhesion kinase (FAK). Tumstatin: It binds to αVβ3 and α3β1 integrins and
  inhibits phosphorylation of FAK, PI3-K, Akt, mTOR, eIF4E and 4E-BP1 to decrease
  endothelial cell protein synthesis and proliferation. In addition tumstatin also
  inhibits NF B mediated signaling in hypoxic conditions leading to the inhibition
  of COX-2, VEGF and bFGF expressions, resulting in inhibition of hypoxic tumor angiogenesis
  and LASER induced CNV. Endostatin: It binds to α5β1 integrin and inhibits phosphorylation
  of FAK, causes inhibition of Ras, Raf, extra cellular signal related kinase-1 (ERK1)
  and p38 MAPK pathways that leads to inhibition of endothelial cell migration and
  tube formation and promotes apoptosis in LASER induced CNV. Arresten: It binds to
  α1β1 integrin and inhibits phosphorylation of FAK, causes inhibition of Ras, Raf,
  ERK1 and p38 MAPK pathways that leads to inhibition of HIF-1a addition arresten
  initiates two apoptotic pathways, involving activation of caspase-9 and -8, leading
  to activation of caspase-3 and PARP cleavage. (a) Arresten activates caspase-3 directly
  through inhibition of FAK/p38-MAPK/ Bcl-2/Bcl-xL and activation of caspase-9; (b)
  Integrin a1b1 cross talk with Fas-L through mitochondrial pathway and leads to activation
  of caspase-8 and-3 in proliferating endothelial cells. Canstatin: It binds to αVβ3/
  αVβ5 integrins and inhibits two apoptotic pathways, involving activation of caspase-8
  and casoase-9, leading to activation of caspase-3. Canstatin activates procaspase-9
  not only through inhibition of the FAK/PI3K/AKT pathways but also by integrins cross
  talking mitochondrial pathway through Fas-L dependent caspase-8 activation leads
  to endothelial cell apoptosis in LASER induced CNV models. CM represents cell membrane.
  Hexastatin: Its receptor and mediated signaling is not yet known.'
pmcid: PMC4172307
papertitle: Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous
  Angioinhibitors.
reftext: Venugopal Gunda, et al. J Cancer Sci Ther. ;5(12):417-426.
pmc_ranked_result_index: '58965'
pathway_score: 0.7755706
filename: nihms-553334-f0001.jpg
figtitle: Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous
  Angioinhibitors
year: ''
organisms: Homo sapiens
ndex: 0d3ce90c-deaf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4172307__nihms-553334-f0001.html
  '@type': Dataset
  description: 'Tumstatin, endostatin, arresten and canstatin interact with αVβ3/
    α3β1, α5β1, α1β1 and αVβ3/ αVβ5 integrins respectively, to inhibit the phosphorylation
    of focal adhesion kinase (FAK). Tumstatin: It binds to αVβ3 and α3β1 integrins
    and inhibits phosphorylation of FAK, PI3-K, Akt, mTOR, eIF4E and 4E-BP1 to decrease
    endothelial cell protein synthesis and proliferation. In addition tumstatin also
    inhibits NF B mediated signaling in hypoxic conditions leading to the inhibition
    of COX-2, VEGF and bFGF expressions, resulting in inhibition of hypoxic tumor
    angiogenesis and LASER induced CNV. Endostatin: It binds to α5β1 integrin and
    inhibits phosphorylation of FAK, causes inhibition of Ras, Raf, extra cellular
    signal related kinase-1 (ERK1) and p38 MAPK pathways that leads to inhibition
    of endothelial cell migration and tube formation and promotes apoptosis in LASER
    induced CNV. Arresten: It binds to α1β1 integrin and inhibits phosphorylation
    of FAK, causes inhibition of Ras, Raf, ERK1 and p38 MAPK pathways that leads to
    inhibition of HIF-1a addition arresten initiates two apoptotic pathways, involving
    activation of caspase-9 and -8, leading to activation of caspase-3 and PARP cleavage.
    (a) Arresten activates caspase-3 directly through inhibition of FAK/p38-MAPK/
    Bcl-2/Bcl-xL and activation of caspase-9; (b) Integrin a1b1 cross talk with Fas-L
    through mitochondrial pathway and leads to activation of caspase-8 and-3 in proliferating
    endothelial cells. Canstatin: It binds to αVβ3/ αVβ5 integrins and inhibits two
    apoptotic pathways, involving activation of caspase-8 and casoase-9, leading to
    activation of caspase-3. Canstatin activates procaspase-9 not only through inhibition
    of the FAK/PI3K/AKT pathways but also by integrins cross talking mitochondrial
    pathway through Fas-L dependent caspase-8 activation leads to endothelial cell
    apoptosis in LASER induced CNV models. CM represents cell membrane. Hexastatin:
    Its receptor and mediated signaling is not yet known.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNKS2
  - PARP2
  - PIK3CG
  - PARP8
  - PIK3CD
  - PIK3R3
  - PARP15
  - PARP4
  - PIK3R6
  - PARP3
  - RELA
  - PIK3CB
  - IKBKG
  - IKBKB
  - NRAS
  - KRAS
  - PARP1
  - NFKB1
  - REL
  - HRAS
  - RELB
  - PIK3R5
  - FASLG
  - HEXA
  - SETD2
  - AKT2
  - BCL2
  - PARP9
  - PARP10
  - TNKS
  - TIPARP
  - VEGFD
  - PIK3R4
  - BMPR2
  - MAPK3
  - PTK2
  - BCL2L1
  - PIK3CA
  - PARP12
  - AKT1
  - PARP14
  - VEGFB
  - VEGFA
  - PGF
  - NFKB2
  - FAS
  - VEGFC
  - EIF4E
  - PARP16
  - PARP11
  - AKT3
  - CHUK
  - MTOR
  - PARP6
  - EIF4EBP1
  - Cancer
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: 065/RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: FasL
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: Hexa
  symbol: HEXA
  source: hgnc_symbol
  hgnc_symbol: HEXA
  entrez: '3073'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Bcl-2/Bcl-x
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: cox-2/DFGF/VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: talk
  symbol: T-ALK
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR2
  entrez: '659'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ?/FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Bcl-2/Bcl-x
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: cox-2/DFGF/VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: cox-2/DFGF/VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: cox-2/DFGF/VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: cox-2/DFGF/VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
